Preclinical and Healthy Volunteer Studies of Potential Drug-Drug Interactions Between Tenapanor and Phosphate Binders.

about

Effect of Food Intake on the Pharmacodynamics of Tenapanor: A Phase 1 Study.Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers.Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis.

P2860

Q38879346-B1CC9ACB-3307-4247-BA3C-CBC37AE3F1E2 Q48179198-D6753BC5-A1BE-44F8-AD0E-40234E10B11F Q55059919-C4883589-CBB8-4661-A25B-27AB0A8BEF82

P2860

Preclinical and Healthy Volunteer Studies of Potential Drug-Drug Interactions Between Tenapanor and Phosphate Binders.

Item

http://www.wikidata.org/entity/Q42025679

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Preclinical and Healthy Volunt ...... napanor and Phosphate Binders.

@en

Preclinical and Healthy Volunt ...... napanor and Phosphate Binders.

@nl

type

Item

label

Preclinical and Healthy Volunt ...... napanor and Phosphate Binders.

@en

Preclinical and Healthy Volunt ...... napanor and Phosphate Binders.

@nl

prefLabel

Preclinical and Healthy Volunt ...... napanor and Phosphate Binders.

@en

Preclinical and Healthy Volunt ...... napanor and Phosphate Binders.

@nl

P1476

Preclinical and Healthy Volunt ...... napanor and Phosphate Binders.

@en

P2093

Andrew G Spencer

http://www.w3.org/2001/XMLSchema#string

Desiree Deshpande

http://www.w3.org/2001/XMLSchema#string

Dominique Charmot

http://www.w3.org/2001/XMLSchema#string

Eric D Labonté

http://www.w3.org/2001/XMLSchema#string

Jill Kohler

http://www.w3.org/2001/XMLSchema#string

Kenji Kozuka

http://www.w3.org/2001/XMLSchema#string

Maria Leonsson-Zachrisson

http://www.w3.org/2001/XMLSchema#string

Mikael Knutsson

http://www.w3.org/2001/XMLSchema#string

Susanne Johansson

http://www.w3.org/2001/XMLSchema#string

P2860

Non-systemic drugs: a critical review

Stool form scale as a useful guide to intestinal transit time

Oral phosphate binders in patients with kidney failure

Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD

Molecular cloning of putative members of the Na/H exchanger gene family. cDNA cloning, deduced amino acid sequence, and mRNA tissue expression of the rat Na/H exchanger NHE-1 and two structurally related proteins.

A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers.

Intestinal inhibition of the Na+/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans.

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD.

P304

448-456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPDD.307

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David P Rosenbaum

P577

2016-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27654985

http://www.w3.org/2001/XMLSchema#string

P932

5599948

http://www.w3.org/2001/XMLSchema#string

Preclinical and Healthy Volunteer Studies of Potential Drug-Drug Interactions Between Tenapanor and Phosphate Binders.

about

P2860

P2860

Preclinical and Healthy Volunteer Studies of Potential Drug-Drug Interactions Between Tenapanor and Phosphate Binders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932